Nattokinase Benefits for Men: What the Evidence Says

Nattokinase supplement bottle alongside traditional Japanese natto in a ceramic bowl with soybeans

In This Article

Key Takeaways

  • A meta-analysis of multiple RCTs found nattokinase significantly reduces both systolic blood pressure (-3.45 mmHg) and diastolic blood pressure (-2.32 mmHg), with one trial showing stronger blood pressure effects in males specifically
  • A clinical study with 1,062 participants showed nattokinase effectively managed atherosclerosis progression and improved lipid profiles in 84-95% of participants over 12 months
  • Clinical trial dosages range from 2,000 FU (blood pressure) to 6,000 FU (lipids), with the Japan Nattokinase Association recommending 2,000 FU/day as standard intake
  • Nattokinase is generally well-tolerated in clinical trials but should not be combined with blood thinners (warfarin, aspirin) without medical supervision due to additive fibrinolytic effects
  • Japanese research reveals quality standards, vitamin K2 removal technology, and synergistic formulations that most international guides overlook

Heart disease remains the leading cause of death for men worldwide — and men tend to develop cardiovascular problems a full decade earlier than women. Yet most men don't discover nattokinase until they're already managing high blood pressure, elevated cholesterol, or poor circulation.

If you've heard about this enzyme from Japanese fermented soybeans, you've probably noticed a problem: almost every guide out there covers nattokinase generically. Very few address what nattokinase specifically means for men's health — even though emerging clinical data suggests men may respond to it differently than women.

We reviewed the clinical research, including a systematic review and meta-analysis of randomized controlled trials, multiple RCTs totaling over 1,500 participants, and Japanese clinical studies rarely cited in English-language guides. This guide breaks down the evidence for each benefit, explains what the research actually shows (and where the gaps are), and helps you decide if nattokinase belongs in your health routine.

What Is Nattokinase?

Nattokinase is a fibrinolytic enzyme produced during the fermentation of soybeans into natto, a traditional Japanese food that has been consumed for centuries. The enzyme was identified by Dr. Hiroyuki Sumi while researching at the University of Chicago, when he discovered that natto could dissolve artificial fibrin — the protein mesh that forms blood clots — with remarkable efficiency [6].

Despite its name, nattokinase is not actually a kinase enzyme. It's a subtilisin-like serine protease — a type of protein-digesting enzyme with 275 amino acids and a molecular weight of approximately 28 kDa. Its activity is measured in FU (fibrinolytic units), a standardized measurement established by the Japan Nattokinase Association (JNKA).

Natto vs. Nattokinase Supplements

Eating natto and taking nattokinase supplements are not the same thing. Natto contains nattokinase but also includes vitamin K2 (menaquinone-7), which promotes blood clotting — the opposite effect of nattokinase. This creates a contradiction: natto's fibrinolytic enzyme works against clotting while its vitamin K2 promotes it.

Japanese manufacturers solved this by developing extraction processes that isolate nattokinase while removing vitamin K2. Products like NSK-SD (a branded nattokinase extract) undergo specific purification to eliminate K2, making the supplement suitable for people who need to avoid vitamin K interference — including those on anticoagulant medications [21].

Why Men Should Pay Attention to Nattokinase

Men's Cardiovascular Risk Profile

The statistics for men's heart health are stark. Cardiovascular disease claims more male lives than any other cause, and men typically develop CVD approximately seven to ten years earlier than women. Hypertension is more prevalent in men under 65 than in women of the same age, and arterial stiffness — a key predictor of cardiovascular events — accelerates in men from their 40s onward.

These aren't just background statistics. They define the specific risk factors that nattokinase has been studied for: blood pressure, arterial health, blood clot prevention, and lipid management.

The Sex-Specific Blood Pressure Finding

One of the most relevant findings for men comes from a randomized, double-blind, placebo-controlled trial conducted in North America. Among 79 participants who took nattokinase (2,000 FU/day) for eight weeks, the blood pressure reduction was more pronounced in male participants. Specifically, men's diastolic blood pressure dropped from 86 mmHg to 81 mmHg (P<0.006 vs. placebo) — a clinically meaningful reduction. This effect was associated with changes in von Willebrand factor, a protein involved in blood clotting and vascular health [5].

This is one of the few studies to report sex-specific subgroup analysis for nattokinase, and it suggests that men may be particularly responsive to its vascular effects.

Evidence-Based Benefits for Men's Health

Blood Pressure Reduction: Strong Evidence

Blood pressure support is nattokinase's most well-documented benefit, backed by multiple randomized controlled trials and a systematic review.

A randomized controlled trial with 86 participants with pre-hypertension or stage-1 hypertension found that nattokinase supplementation for eight weeks significantly reduced systolic blood pressure by 9.1% and diastolic blood pressure by 6% compared to placebo [4].

A systematic review and meta-analysis pooling data from multiple RCTs confirmed these findings, reporting average reductions of 3.45 mmHg (systolic) and 2.32 mmHg (diastolic) [1]. While these numbers may seem modest, they're comparable to lifestyle interventions like reducing sodium intake, and for men with borderline or elevated blood pressure, they could make a meaningful difference in long-term cardiovascular risk.

Atherosclerosis and Arterial Health: Strong Evidence

A clinical study with 1,062 participants followed over 12 months found that nattokinase supplementation effectively managed atherosclerosis progression. The study reported that plaque did not advance during the treatment period, and lipid profiles improved significantly. Benefits were most pronounced in higher-risk groups, including smokers and those with elevated BMI — demographics that overlap heavily with men at cardiovascular risk [2].

A separate 26-week trial with 76 patients found that higher-dose nattokinase (6,500 FU/day) reduced carotid intima-media thickness and plaque size — direct measures of arterial health [6].

Important context: A three-year randomized controlled trial (the NAPS study) with 265 individuals without clinical cardiovascular disease did not find significant reduction in subclinical atherosclerosis or blood pressure at 2,000 FU/day [3]. This suggests nattokinase's benefits may be more pronounced in those who already have risk factors — which, for men over 40, is common.

Cholesterol and Lipid Management: Moderate Evidence

Multiple trials support nattokinase's effects on blood lipids, though results are dose-dependent.

The 1,062-participant study reported that 84-95% of participants showed improved lipid profiles over 12 months, including reductions in total cholesterol, LDL-C, and triglycerides, with HDL-C increasing by 15.8% (P<0.01) [2].

A randomized, double-blind, placebo-controlled trial combining nattokinase with red yeast rice in patients with stable coronary artery disease found significant reductions in triglycerides (-0.39 mmol/L), total cholesterol (-0.66 mmol/L), and increased HDL-C (+0.195 mmol/L) compared to placebo [7].

A comprehensive review of nattokinase lipid-lowering effects notes the recommended dose for lipid maintenance is 2,000-4,000 FU daily [11].

Blood Clot Prevention and Circulation: Strong Evidence

Nattokinase's original claim to fame — its ability to support healthy blood clot breakdown — remains its most consistent finding across studies.

A Japanese clinical trial involving 10 healthy adult males demonstrated that oral nattokinase administration produced significant increases in D-dimer (a marker of clot breakdown) and antithrombin concentration, with prolonged activated partial thromboplastin time (APTT) — all indicating enhanced fibrinolytic activity [15].

An eight-week trial with 45 participants taking 4,000 FU/day confirmed reductions in fibrinogen and factor VII, two key clotting factors, independent of participants' baseline health status [6].

For men, healthy circulation matters beyond cardiovascular disease prevention. Blood flow affects everything from exercise recovery to cognitive sharpness to sexual function. While no clinical trials have specifically tested nattokinase for erectile function, the enzyme's documented effects on blood flow and vascular health address several of the same circulatory factors that contribute to men's sexual health.

Brain Health: Emerging Evidence

Research on nattokinase's neuroprotective effects is still mostly preclinical, but the findings are intriguing.

Laboratory and animal studies show nattokinase can degrade amyloid-beta peptides — the protein fragments implicated in Alzheimer's disease — both in vitro and in living organisms [12]. Additional studies demonstrate neuroprotective effects against inflammation-driven brain damage and blood-brain barrier dysfunction [13].

The first randomized controlled trial evaluating nattokinase for cognition in patients with asymptomatic intracranial or carotid stenosis found it did not improve global cognition but showed potential improvement in visuospatial function [9]. This is honest, nuanced evidence — not a breakthrough, but a signal worth monitoring.

Anti-Inflammatory Properties: Emerging Evidence

Nattokinase demonstrates anti-inflammatory and antioxidant effects in preclinical research. One study found it attenuated hepatic and neural toxicity through activation of the Nrf2 pathway and suppression of inflammatory mediators [14]. A comprehensive review positions nattokinase as an adjuvant therapeutic strategy for non-communicable diseases, citing its anti-inflammatory and antioxidant properties alongside its better-established fibrinolytic effects [10].

For men, chronic low-grade inflammation is increasingly recognized as a driver of age-related health decline, including cardiovascular disease and metabolic dysfunction. However, most anti-inflammatory evidence for nattokinase comes from animal models, so these benefits should be considered supportive rather than primary.

How Nattokinase Works in the Body

Nattokinase operates through several complementary mechanisms that together support cardiovascular health:

Direct fibrinolysis. Nattokinase directly breaks down fibrin, the protein mesh that forms the structural basis of blood clots. It acts similarly to plasmin, the body's own clot-dissolving enzyme, but with broader substrate specificity.

t-PA enhancement. Nattokinase stimulates tissue plasminogen activator (t-PA), the enzyme responsible for converting plasminogen to plasmin. This amplifies the body's natural fibrinolytic capacity beyond what nattokinase achieves directly.

Clotting factor reduction. Clinical trials show nattokinase reduces levels of fibrinogen and factor VII — two proteins essential for clot formation [6].

Blood pressure modulation. Nattokinase exhibits ACE-inhibiting activity, similar to the mechanism of commonly prescribed ACE inhibitor medications. It also reduces von Willebrand factor, which contributes to blood viscosity [5].

Lipid effects. At higher doses, nattokinase appears to reduce total cholesterol, LDL-C, and triglycerides while raising HDL-C, though the mechanisms are less well understood than its fibrinolytic effects.

Importantly, nattokinase's safety margin has been reported as three times higher than pharmaceutical tissue plasminogen activators (tPA drugs used in emergency stroke treatment), suggesting a more gentle fibrinolytic action [1].

Dosage, Timing, and How to Take It

Recommended Dosage

Clinical trials have tested nattokinase across a range of doses, with benefits observed at different thresholds for different outcomes:

Dosage (FU/day) Primary Evidence Duration Studied
2,000 FU Blood pressure reduction, vWF reduction 8 weeks
4,000 FU Reduced clotting factors (fibrinogen, factor VII) 8 weeks
6,000-6,500 FU Lipid improvement, atherosclerosis management 26-52 weeks

The Japan Nattokinase Association recommends 2,000 FU/day as the standard intake for general cardiovascular support. For context, this is equivalent to approximately 100mg of nattokinase extract, though exact conversion depends on the purity of the extract.

When to Take Nattokinase

Some researchers suggest taking nattokinase in the evening or before bed. The rationale: cardiovascular events like heart attacks and strokes peak in the early morning hours, and nattokinase's fibrinolytic activity could provide overnight vascular support during this higher-risk window. However, this timing recommendation is based on physiological reasoning rather than comparative clinical trials, so taking it at whatever time supports consistency is reasonable.

Nattokinase can be taken with or without food. Some evidence suggests food may support absorption, but clinical trials have not consistently controlled for this variable.

How Long Until Results?

Different effects have different timelines:

  • Fibrinolytic markers: Changes detectable within hours of a single dose
  • Blood pressure: Significant reductions typically observed after 4-8 weeks of daily use
  • Lipid improvements: Most studies show meaningful changes at 12-26 weeks
  • Arterial health: Long-term effects studied over 6-12 months

Consistency matters more than timing. The benefits accumulate with regular daily use.

Safety Considerations for Men

Overall Safety Profile

Nattokinase has demonstrated a favorable safety profile across multiple clinical trials. No serious adverse events have been reported at doses up to 6,500 FU/day in studies lasting up to 12 months. Toxicology studies confirm no adverse effects at doses up to 10 mg/kg/day for 28 days in humans, and no liver, kidney, or genotoxicity concerns in standard testing [6].

A Japanese safety study (registered under UMIN000017512) tested NSK-SD nattokinase extract at five times the recommended daily dose in healthy adults aged 20-64 and confirmed safety [16].

Possible Side Effects

Side effects are uncommon and generally mild when reported:

  • Mild gastrointestinal discomfort (rare)
  • Potential for increased bleeding risk at high doses or in sensitive individuals
  • Rare allergic reactions (related to soy protein, not nattokinase itself)

Drug Interactions — Critical for Men

Many men over 40 take one or more cardiovascular medications. Understanding nattokinase's interactions is essential:

Medication Type Interaction Risk Recommendation
Blood thinners (warfarin, heparin) Additive fibrinolytic effects — increased bleeding risk Consult physician before combining. One study of 153 patients found no adverse interactions at 100mg/day with enoxaparin/fondaparinux, but medical supervision is essential [18]
Antiplatelet drugs (aspirin, clopidogrel) Potential additive anticoagulant effect Medical supervision required
Blood pressure medications Possible additive hypotensive effect Monitor blood pressure closely; meta-analysis shows -3.45/-2.32 mmHg reduction [1]
Statins No safety issues identified in combination trials A 90-day trial combining nattokinase with red yeast rice showed no adverse effects [7]
ED medications No direct interaction data Both affect blood flow; consult physician before combining

Who Should Avoid Nattokinase

  • People with bleeding disorders — nattokinase's fibrinolytic activity could worsen bleeding
  • Anyone scheduled for surgery — discontinue at least two weeks before procedures
  • People with soy allergies — nattokinase is derived from soy fermentation
  • Those on anticoagulant therapy without medical supervision — the combination requires professional monitoring
  • Pregnant or nursing women — insufficient safety data in these populations

Realistic Expectations

Nattokinase is not a medication. It will not replace prescribed blood pressure drugs, statins, or anticoagulants. The clinical evidence supports it as a complementary approach — something that works alongside (not instead of) medical treatment and healthy lifestyle choices. The most honest summary: nattokinase offers modest but measurable cardiovascular support, particularly for blood pressure and fibrinolytic activity, and the effects are enhanced with consistent daily use over months.

What Japanese Research Reveals That Most Guides Miss

JNKA: A Quality Standard Most Consumers Don't Know Exists

The Japan Nattokinase Association (JNKA) has established standardized quality criteria for nattokinase products, including a certified measurement protocol for FU (fibrinolytic units). This matters because without standardization, "nattokinase" could mean very different things across products. JNKA-certified products undergo testing to verify their actual fibrinolytic activity matches label claims [21].

Why this matters: When choosing a nattokinase supplement, look for JNKA-standard FU measurements. A product claiming "2,000 FU" without referencing a validated testing method may not deliver the activity you expect.

The Vitamin K2 Removal Innovation

Japanese manufacturers recognized a fundamental contradiction in natto: the food contains both nattokinase (which supports healthy blood flow) and vitamin K2 (which promotes clotting). For people taking anticoagulant medications, this combination is problematic. Japanese extraction technology — notably the NSK-SD process — specifically removes vitamin K2 from nattokinase supplements while preserving the enzyme's fibrinolytic activity [16].

A JNKA-sponsored study confirmed that appropriate nattokinase doses in cardiovascular patients already taking warfarin produced stable coagulation parameters with no adverse effects — a finding that challenges the blanket advice to "avoid nattokinase if you take blood thinners" [21].

Why this matters: Not all nattokinase supplements remove vitamin K2. If you take anticoagulant medications, Japanese supplements with K2 removal (like NSK-SD-based products) offer a documented safety advantage.

Synergistic Formulations vs. Single-Ingredient Approaches

While most international nattokinase supplements contain nattokinase alone, Japanese manufacturers often take a multi-ingredient approach. For example, Kobayashi Pharmaceutical's Nattokinase EX combines nattokinase with EPA, DHA, sardine peptides (containing valytyrosine for ACE-inhibiting activity), and tochu leaf extract (for vascular flexibility). Each ingredient targets a different cardiovascular pathway.

This reflects a broader pattern in Japanese supplement design: rather than isolating a single active compound, formulations combine multiple ingredients that address the same health concern through complementary mechanisms.

Why this matters: A synergistic formula may address cardiovascular health more comprehensively than nattokinase alone, though head-to-head clinical comparisons between single-ingredient and multi-ingredient nattokinase products are limited.

Japanese Safety Testing Goes Further Than Standard

Japanese clinical trials on nattokinase include overdose safety studies — specifically testing five times the recommended dose in healthy adults to confirm safety margins [16]. Additionally, Japanese trials have registered warfarin co-administration studies to establish practical guidelines for patients on anticoagulant therapy, rather than simply advising avoidance.

This level of systematic safety investigation provides a more nuanced picture than the typical "avoid if taking blood thinners" guidance found in most international resources.

Why this matters: Japanese research provides specific safety parameters (dose limits, drug co-administration data) rather than blanket warnings, giving healthcare providers better information for patient-specific decisions.

Natto Consumption and Cardiovascular Health in Japan

Japan consistently ranks among the highest in the world for male life expectancy. While this is attributable to many dietary and lifestyle factors, regional data within Japan hints at a natto connection: areas with higher natto consumption tend to have lower cardiovascular mortality rates. However, these are observational associations with significant confounding factors — natto-consuming regions may also have other dietary and lifestyle patterns that contribute to better health outcomes.

Why this matters: The epidemiological data provides context but not proof. It's one piece of a larger puzzle that includes clinical trial evidence. Be cautious of claims that natto "explains" Japanese longevity — the reality is more complex.

Our Recommendations

We carry three nattokinase products, each suited to different needs. All are from established Japanese manufacturers with documented quality standards.

Kobayashi Nattokinase EX (30-Day Supply)

Why We Selected This: From Kobayashi Pharmaceutical, one of Japan's most established healthcare companies. We chose this for men who want comprehensive cardiovascular support because it combines nattokinase (2,500 FU) with EPA (13mg), DHA (72mg), sardine peptides, and tochu leaf extract — addressing circulation, blood lipids, blood pressure, and vascular flexibility through multiple pathways. The vitamin K2 has been removed from the nattokinase extract.

This multi-ingredient approach mirrors the synergistic formulation philosophy we highlighted in the Japanese research section. For men looking at overall cardiovascular maintenance rather than maximum nattokinase potency alone, this is our primary recommendation.

View Kobayashi Nattokinase EX →

View Kobayashi Nattokinase EX →

ORIHIRO Nattokinase 4000

Why We Selected This: From ORIHIRO, a trusted Japanese supplement manufacturer. We chose this for men who want maximum nattokinase potency — 4,000 FU per daily serving. This dosage matches the level used in clinical trials demonstrating significant reductions in clotting factors (fibrinogen, factor VII). A straightforward, high-potency option for those who prefer a focused, single-purpose nattokinase supplement.

View ORIHIRO Nattokinase 4000 →

View ORIHIRO Nattokinase 4000 →

Noguchi Nattokinase HQ 4000FU

Why We Selected This: From the Noguchi Medical Research Institute, a name associated with medical-grade quality standards. We chose this for men who prioritize research credentials — the Noguchi name carries weight in Japanese healthcare. At 4,000 FU per serving, it matches the clinical trial dosage for fibrinolytic effects.

View Noguchi Nattokinase HQ 4000FU →

View Noguchi Nattokinase HQ 4000FU →

Product Comparison

Feature Kobayashi Nattokinase EX ORIHIRO Nattokinase 4000 Noguchi Nattokinase HQ
FU per serving 2,500 FU 4,000 FU 4,000 FU
Additional ingredients EPA, DHA, sardine peptides, tochu leaf extract Focused nattokinase Focused nattokinase
Vitamin K2 removed Yes Check label Check label
Best for Comprehensive cardiovascular support Maximum nattokinase potency Research-backed quality
Serving size 2 capsules/day Per label Per label
Supply 30 days 30 days 30 days

Conclusion

Nattokinase offers men a well-researched, evidence-based approach to cardiovascular support. The strongest evidence points to meaningful blood pressure reduction — with data suggesting men may respond more robustly than the general population — along with fibrinolytic activity that supports healthy circulation and arterial health maintenance over time.

The evidence is encouraging but honest: nattokinase is not a medication replacement, and its effects are modest rather than dramatic. What sets it apart is its multi-mechanism approach to cardiovascular health, its strong safety profile, and the depth of Japanese research that reveals quality standards and formulation innovations most international guides overlook.

For men over 40 managing blood pressure, monitoring cholesterol, or simply investing in long-term cardiovascular health, nattokinase deserves consideration — ideally in conversation with your healthcare provider, especially if you take any medications.

This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any supplement regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions

Avoid combining nattokinase with blood-thinning medications (warfarin, heparin, aspirin, clopidogrel) without medical supervision. The enzyme's fibrinolytic activity can add to the effects of anticoagulant drugs, potentially increasing bleeding risk. Also stop nattokinase at least two weeks before any scheduled surgery.
Research suggests nattokinase may slow or prevent atherosclerosis progression rather than "clean" existing plaque. A clinical study with 1,062 participants found that nattokinase supplementation over 12 months prevented plaque advancement, and a 26-week trial showed reduced carotid intima-media thickness. However, describing it as "cleaning arteries" overstates the evidence. It's better characterized as supporting arterial health maintenance.
Fibrinolytic effects (enhanced clot breakdown) are detectable within hours of a single dose. Blood pressure improvements typically appear after four to eight weeks of consistent daily use. Lipid and cholesterol changes require 12-26 weeks. The effects are cumulative, so daily consistency is more important than timing.
Daily supplementation with 2,000-4,000 FU has been shown to reduce blood clotting factors (fibrinogen, factor VII), lower blood pressure, and improve blood flow markers. An eight-week trial with 4,000 FU/day confirmed reduced clotting factors independent of participants' health status. Long-term safety has been documented in studies lasting up to 12 months with over 1,000 participants.
Nattokinase can have an additive blood-pressure-lowering effect. A meta-analysis found average reductions of 3.45/2.32 mmHg. If you're already on antihypertensive medication, consult your doctor before adding nattokinase. Your dosage may need adjustment, and blood pressure should be monitored more closely during the initial weeks.
No clinical trials have tested nattokinase specifically for erectile function. However, nattokinase improves blood flow through fibrinolytic activity, blood pressure reduction, and vascular health support — all factors that contribute to healthy erectile function. The documented sex-specific blood pressure response in males is encouraging, but direct evidence for ED treatment does not exist. Nattokinase may support the vascular conditions that enable healthy function, but it should not be considered an ED treatment.
Based on clinical evidence, 2,000 FU/day is the standard recommendation for general cardiovascular support and blood pressure maintenance. For targeted fibrinolytic effects (clotting factor reduction), studies show benefits at 4,000 FU/day. Higher doses (6,000+ FU) have been used in lipid and atherosclerosis studies. Start at 2,000 FU and consult a healthcare provider before increasing.
No. Natto contains nattokinase but also includes vitamin K2, which promotes blood clotting — the opposite of nattokinase's fibrinolytic effect. Nattokinase supplements, particularly Japanese-made ones, typically extract the enzyme while removing vitamin K2. Supplements also provide a standardized dose measured in FU, whereas the nattokinase content of natto varies based on fermentation conditions.
Current evidence suggests nattokinase is safe to combine with statins. A 90-day randomized trial combining nattokinase with red yeast rice (which contains naturally occurring statin-like compounds) found no adverse effects and improved cardiac biomarkers. However, always inform your physician about all supplements you take.
Clinical trials and toxicology studies have not found adverse liver effects from nattokinase. Subchronic rodent studies tested doses up to 1,000 mg/kg/day without hepatic toxicity, and human trials monitoring liver enzymes (AST/ALT) showed no concerning changes. An ongoing clinical trial continues to monitor liver function as part of its safety protocol.
Toxicology studies show no renal toxicity from nattokinase. Human trials monitoring kidney function markers (BUN, creatinine, eGFR) found no adverse effects after 12 weeks of supplementation. While nattokinase has not been specifically studied as a kidney-protective supplement, it does not appear to pose any risk to kidney health at studied doses.
There's a physiological argument for evening intake: cardiovascular events peak in early morning hours, and nattokinase's fibrinolytic activity during overnight hours could provide protection during this vulnerable window. However, no clinical trials have directly compared morning vs. evening dosing. The most important factor is taking it consistently at whatever time works for your routine.
  1. Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of RCTs
  2. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants
  3. Nattokinase atherothrombotic prevention study: A randomized controlled trial
  4. Effects of nattokinase on blood pressure: a randomized, controlled trial
  5. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor
  6. Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases
  7. Lipid-lowering, antihypertensive, and antithrombotic effects of nattokinase combined with red yeast rice
  8. The effect of Nattokinase-Monascus supplements on dyslipidemia
  9. Nattokinase supplementation for cognitive enhancement in asymptomatic intracranial/carotid stenosis
  10. Nattokinase as an adjuvant therapeutic strategy for non-communicable diseases
  11. Research progress of nattokinase in reducing blood lipid
  12. Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
  13. Nattokinase as a potential therapeutic agent for preventing blood-brain barrier dysfunction
  14. Nattokinase attenuates bisphenol A or gamma irradiation-mediated hepatic and neural toxicity
  15. Japanese Clinical Trial — NK oral administration in healthy males
  16. Japanese Safety Trial — NSK-SD 5× dose safety study
  17. Comparative cardioprotective effectiveness: NOACs vs. Nattokinase
  18. Safety of nattokinase with anticoagulants in vascular disease patients
  19. Effect of Nattokinase on the Blood Flow Improvement in Healthy Subjects

Continue Reading

Related Articles

gut brain connection

Gut-Brain Connection: Science, Supplements & Safety

April 27, 2026
memory support supplement

Memory Support Supplements: What Works

April 27, 2026
gut brain axis

Gut-Brain Axis: How Your Gut Affects Your Mind

April 26, 2026